MAJOR PFIZER CANADA INVESTMENT IN QUEBEC TOWARDS FACILITY MODERNIZATION

OTTAWA, June 21, 2011 /CNW/ - The following is a statement by Russell Williams, President of Canada's Research-Based Pharmaceutical Companies (Rx&D), in response to an announcement made earlier today by Pfizer Canada of a $22 million investment towards the modernization of its headquarters facility in Kirkland, Quebec.

"This major Pfizer Canada investment speaks to the importance of the pharmaceutical industry in the province of Quebec. This contribution of $22 million will allow Pfizer Canada to consolidate the pharmaceutical and veterinary workforce of its Canadian headquarters. Pfizer Canada is a strong contributor to the Quebec economy. Almost 2,100 employees work at its headquarters and in other regions of Quebec.

"The new facilities and equipment will allow Pfizer Canada employees to work more closely while making the most of the renovated spaces. The building renovations are based on an open concept which will facilitate the sharing of ideas, information, security, effectiveness and productivity.

"Established in Quebec for almost 60 years, Pfizer Canada has continued to strengthen its presence in the province and is a pharmaceutical industry leader in Canada. With this investment, Pfizer Canada will continue to attract high-quality jobs and ensure a substantial economic impact."

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines.  Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.

SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX

For further information:

Christine Choury
Media Relations
Telephone: 613.236.0455
Email: cchoury@canadapharma.org

Profil de l'entreprise

CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.